Veterinary Medicine Information website

Nobilis RT + IBmulti + G + ND, Injekční emulze

Authorised
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated

Product identification

Medicine name:
Nobilis RT + IBmulti + G + ND, Injekční emulze
Active substance:
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    1.00
    Dose
  • Newcastle disease virus, strain Clone 30, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    1.00
    Dose
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain D78, Inactivated
    14.50
    log2 virus neutralising unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/015/00-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 27/06/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022